Fund
NVIDIA
Page built from the operations logged, not from a written profile. It says nothing about the fund's activity outside the scope of Bolus, which is health venture capital in Europe and the United States.
- Operations logged
- 3
- Lead
- 1
- New entries
- 1
- Follow ons
- 1
- Latest operation
- 23 September 2026
- Sectors
- Biotech
Operations
| Date | Company | Stage | Amount | Role |
|---|---|---|---|---|
| 23 Sept | United Kingdom, Biotech | Series C | 140 M$ | Participant |
| 09 Sept | United States | Undisclosed | not established | Lead |
| 03 Sept | United States, Biotech | Series B | 60 M$ | Existing investor |
Co investors 24 funds crossed
- Catalio Capital Management 2 operations
- André Hoffmann, vice-président de Roche, à titre personnel 1 operation
- Anthology Fund (Anthropic) 1 operation
- BVF Partners 1 operation
- Cooley 1 operation
- CU Healthcare Innovation Fund II 1 operation
- Deep Track Capital 1 operation
- Eli Lilly and Company 1 operation
- European Tech Collective 1 operation
- Firebrand River Capital 1 operation
- Gaingels 1 operation
- Inception Fund 1 operation
- Insight Partners 1 operation
- King Philanthropies 1 operation
- NATO Innovation Fund 1 operation
- Perceptive Advisors 1 operation
- PostScriptum 1 operation
- RA Capital Management 1 operation
- Redalpine 1 operation
- S32 1 operation
- Singular 1 operation
- Sovereign AI 1 operation
- The Rockefeller Foundation 1 operation
- True Ventures 1 operation
Funds that appeared in the same rounds, in any capacity. Geographies logged: United Kingdom, United States.